Abstract:Highlights • Tetrahedral framework nucleic acid (FNA) nanomaterials-mediated microRNAs (miRNAs) were involved in the hepatocyte differentiation of human adipose-derived mesenchymal stem cells (ADMSCs). • A simple and cost-effective system was established to one-step induce hepatic differentiation of ADMSCs, and further develop liver organoids from induced functional hepatocyte-like cells. • Transcriptome analysis revealed the potential action mechanism of inducing ADMSCs to differentiate into hepatocytes based on FNA-miRNA, which could be an extendable strategy for other small RNA. • Cell therapy based on HLCs and Hep:HUE-Liver spheroids represented a promising strategy for effective acute liver failure therapy. The specific induction of hepatic differentiation presents a significant challenge in developing alternative liver cell sources and viable strategies for clinical therapy of acute liver failure (ALF). The past decade has witnessed the blossom of microRNAs in regenerative medicine. Herein, microRNA 122-functionalized tetrahedral framework nucleic acid (FNA-miR-122) has emerged as an unprecedented and potential platform for directing the hepatic differentiation of adipose-derived mesenchymal stem cells (ADMSCs), which offers a straightforward and cost-effective method for generating functional hepatocyte-like cells (FNA-miR-122-iHep). Additionally, we have successfully established a liver organoid synthesis strategy by optimizing the co-culture of FNA-miR-122-iHep with endothelial cells (HUVECs), resulting in functional Hep:HUE-liver spheroids. Transcriptome analysis not only uncovered the potential molecular mechanisms through which miR-122 influences hepatic differentiation in ADMSCs, but also clarified that Hep:HUE-liver spheroids could further facilitate hepatocyte maturation and improved tissue-specific functions, which may provide new hints to be used to develop a hepatic organoid platform. Notably, compared to transplanted ADMSCs and Hep-liver spheroid, respectively, both FNA-miR-122-iHep-based single cell therapy and Hep:HUE-liver spheroid-based therapy showed high efficacy in treating ALF in vivo. Collectively, this research establishes a robust system using microRNA to induce ADMSCs into functional hepatocyte-like cells and to generate hepatic organoids in vitro, promising a highly efficient therapeutic approach for ALF. Graphical abstract Download: Download high-res image (285KB) Download: Download full-size image

MicroRNA‐Modified DNA Hexahedron‐Induced Hepatocyte‐Like Cells Integrating 3D Printed Scaffold for Acute Liver Failure Therapy (Adv. Funct. Mater. 38/2024)

Fabrication of Liver Microtissue with Liver Decellularized Extracellular Matrix (decm) Bioink by Digital Light Processing (DLP) Bioprinting

Liver Fibrosis Therapy Based on Biomimetic Nanoparticles Which Deplete Activated Hepatic Stellate Cells.

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

3D printing incorporating gold nanozymes with mesenchymal stem cell-derived hepatic spheroids for acute liver failure treatment

Framework nucleic Acid-MicroRNA mediated hepatic differentiation and functional hepatic spheroid development for treating acute liver failure

Three-dimensional Culture in a Microgravity Bioreactor Improves the Engraftment Efficiency of Hepatic Tissue Constructs in Mice

Smart Microneedle Arrays Integrating Cell‐Free Therapy and Nanocatalysis to Treat Liver Fibrosis (Adv. Sci. 31/2024)

Smart Microneedle Arrays Integrating Cell‐Free Therapy and Nanocatalysis to Treat Liver Fibrosis

Constructing biomimetic liver models through biomaterials and vasculature engineering

Human Hepatocytes Loaded in 3D Bioprinting Generate Mini-Liver.

Hydrogel Microfluidic‐based Liver‐on‐a‐chip: Mimicking the Mass Transfer and Structural Features of Liver

Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes

Biomimetic hepatic lobules from three-dimensional imprinted cell sheets

3D bioprinting of Liver Microenvironment Model Using Photocrosslinkable Decellularized Extracellular Matrix based Hydrogel

Microfluidic Fabrication of MicroRNA-Induced Hepatocyte-Like Cells/Human Umbilical Vein Endothelial Cells-Laden Microgels for Acute Liver Failure Treatment

Combining human liver ECM with topographically featured electrospun scaffolds for engineering hepatic microenvironment

Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering

Novel integrative methodology for engineering large liver tissue equivalents based on three-dimensional scaffold fabrication and cellular aggregate assembly.

Rapid prototyping of three-dimensional cell/matrix constructs

Liver-specific delivery of spherical DNA frameworks for alleviation of hepatic ischemic reperfusion injury